PlainRecalls
FDA Drug Low Class III Terminated

Zynrelef (bupivacaine and meloxicam), 400 mg bupivacaine and 12 mg meloxicam single dose application, packaged in a kit, Rx only, Manufactured for Heron Therapeutics, Inc., San Diego, CA, NDC 47426-301-02

Reported: August 24, 2022 Initiated: August 2, 2022 #D-1335-2022

Product Description

Zynrelef (bupivacaine and meloxicam), 400 mg bupivacaine and 12 mg meloxicam single dose application, packaged in a kit, Rx only, Manufactured for Heron Therapeutics, Inc., San Diego, CA, NDC 47426-301-02

Reason for Recall

Defective Delivery System: An incorrect 10 mL (12 mL) Luer (slip) syringe packaged in one lot of Zynrelef 400 mg/12 mg kit

Details

Recalling Firm
HERON THERAPEUTICS, INC.
Units Affected
1790 kits
Distribution
U.S.A. Nationwide
Location
San Diego, CA

Frequently Asked Questions

What product was recalled?
Zynrelef (bupivacaine and meloxicam), 400 mg bupivacaine and 12 mg meloxicam single dose application, packaged in a kit, Rx only, Manufactured for Heron Therapeutics, Inc., San Diego, CA, NDC 47426-301-02. Recalled by HERON THERAPEUTICS, INC.. Units affected: 1790 kits.
Why was this product recalled?
Defective Delivery System: An incorrect 10 mL (12 mL) Luer (slip) syringe packaged in one lot of Zynrelef 400 mg/12 mg kit
Which agency issued this recall?
This recall was issued by the FDA Drug on August 24, 2022. Severity: Low. Recall number: D-1335-2022.